期刊文献+

老年H型高血压患者踝臂指数变化的临床意义 被引量:6

Clinical implications of ankle brachial index in elderly patients with H type hypertension
下载PDF
导出
摘要 目的探讨老年H型高血压患者踝臂指数(ABI)的异常情况及临床意义。方法选择127例患者,根据血浆高同型半胱氨酸和诊室血压水平分为H型高血压组(HH组)65例、非H型高血压组(NHH组)32例和正常血压组(NT组)30例。测定ABI、高敏C反应蛋白(hs-CRP)、髓过氧化物酶(MPO)水平和血管内皮功能。结果与NT组比较,HH组和NHH组ABI明显降低(P<0.05,P<0.01);与NHH组比较,HH组ABI明显降低(P<0.05)。与NT组比较,HH组MPO、hs-CRP明显升高,内皮依赖性舒张功能(FMD)明显降低(P<0.05,P<0.01);与NHH组比较,HH组FMD明显降低(P<0.05)。相关分析显示,HH组ABI与hs-CRP和MPO呈负相关(r=-0.739、r=-0.723,P<0.01),与FMD呈正相关(r=0.927,P<0.01)。结论 ABI降低与炎性反应及血管内皮功能受损密切相关,对评估老年H型高血压患者动脉功能损害及识别高危患者有重要的临床意义。 Objective To study the clinical implications of ankle brachial index (ABI) in elderly pa- tients with H type hypertension. Methods One hundred and twenty-seven elderly patients were divided into H type hypertention (HH) group (n= 65),non-H type hypertension (NHH) group (n=32) and normotension (NT) group (n=30). Their ABI,serum hs-CRP and MPO levels,endo- thelial dependent flow-mediated dilation(FMD)were measured. Results The ABI was significant- ly lower in HH group and NHH group than in NT group (P〈0. 05,P〈0.01) and in HH group than in NHH group (P〈0.05). The serum MPO and hs-CRP levels were significantly higher in HH group than in NT group (P〈0.05)while the endothelial dependent FMD was significantly lower in HH group than in NHH group (P〈0.05). The ABI was negatively related with the ser- um MPO and hs-CRP levels and positively related with the endothelial dependent FMD in HH group (r= --0. 739,r=-0. 723,P〈0.01;r=0. 927,P〈0.01). Conclusion Reduced ABI is closely related with inflammatory reactions and vascular endothelial function impairment, and plays an important role in diagnosis of artery function impairment and high risk of H type hyper- tension in elderly hypertensive patients.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2014年第4期367-369,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 高血压 高半胱氨酸 C反应蛋白质 过氧化物酶 内皮 血管 hypertension homocysteine C-reactive protein peroxidase endothelium, vascular
  • 相关文献

参考文献13

  • 1Wald DS, Morris JK, Wald NJ. Reconciling the evidence on serum homocysteine and ishaemie heart disease. PLoS One, 2011,6 ;e16473.
  • 2张岩,霍勇.伴同型半胱氨酸升高的高血压——“H型”高血压[J].心血管病学进展,2011,32(1):3-6. 被引量:235
  • 3Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals:a nationwide study. J Neurol Sci, 2010,298: 153- 157.
  • 4Weatherley BD, Nelson JJ, Heiss G, et al. The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study, 1987- 2001. BMC Cardiovasc Disord, 2007,7 : 3.
  • 5牛俊芳,李佳.急性冠状动脉综合征患者白细胞介素-18的变化及其临床意义[J].心血管病学进展,2013,34(1):118-120. 被引量:2
  • 6Pearson TL. Ankle brachial index as a prognostic tool for women with coronary artery disease. J Cardiovasc Nuts, 2010,25:20- 24.
  • 7Rizvi S,Kamran H, Salciccioli L, et al. Relation of the ankle brachial index to left ventricular ejection fraction. Am J Cardi ol, 2010,105 : 129-132.
  • 8Mikael LG, Rozen R. Homocysteine modulates the effect of simvastatin on expression of ApoA-1 and NF-(kappa) B/ iNOS. Cardiovasc Res,2008,80:151- 158.
  • 9Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem, 2008,54 : 24- 28.
  • 10龙曼,唐晓明,陈爱华.C反应蛋白、脂蛋白相关磷脂酶A2、髓过氧化物酶在冠心病预测中的作用[J].实用医学杂志,2013,29(3):498-500. 被引量:13

二级参考文献69

  • 1Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 2Reinhart K,Bayer O,Brunkhorst F,et al.Markers of endothelial damage in organ dysfunction and sepsis[J].Crit Care Med,2002,30 (5):302.
  • 3Loomans CJ,Dekoning EJ,Staal FJ,et al.Endothelial progenitor cell dysfunction in type-1 diabetes:another consequence of oxidative stress[J].Antioxid Redox Signal,2005,7 (11-12):1468.
  • 4Goon PK,Lip GY,Boos CJ,et al.Circulating endothelial cells,endothelial progenitor cells and endothelial microparticles in cancer[J].Neoplasia,2006,8 (2):79.
  • 5Anderson TJ.Assessment and treatment of endothelium dysfunction in humans[J].J Am Coll Cardiol,1999,34:631-638.
  • 6Bannerman DD,Goldblum SE.Direct effects of endotoxin on the endothelium:barrier function and injury[J].Lab Invest,1999,79:1181-1199.
  • 7Roh J,Chang CL,Alka B,et al.Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes[J].J Biol Chem,2004,279 (8):7264-7274.
  • 8Charles CJ,Rademaker MT,Richards AM,et al.Hemodynamic,hormonal,and renal actions of adrenomedullin-2 in normal conscious sheep[J].Endocrinology,2006,147 (4):1871-1877.
  • 9Kobayashi Y,Liu YJ,Gonda T,et al.Coronary vasodilatory response to a novel peptide,adrenomedullin 2[J].Clin Exp Pharmacol Physiol,2004,31 (suppl 2):49-50.
  • 10Chugh A,Bakris GL.Microalbuminuria:what is it? Why is it important? What should be done about it? An update[J].J Clin Hypertens,2007,9(3):196-200.

共引文献298

同被引文献48

  • 1王瑾,李月华,陈玉华,张峻峰,沈卫峰.踝臂指数与冠状动脉病变程度的研究[J].医学临床研究,2007,24(5):710-712. 被引量:5
  • 2Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ,2003,326:1419 -1424.
  • 3Graham IM,Daly I.E,Refsum HM,et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA,1997,277:1775 -1781.
  • 4Guagnano MT, Ferroni P, Santilli F, et al. Determinants of platelet activation in hypertensives with microalhuminuria. Free Radic Biol Med,2009,46 :922 -927.
  • 5Gkaliagkousi E,Gavriilakl E, Yiannaki E, et al. Platelet activa tion in essential hypertension during exercise: pre- and post treatment changes with an angiotensin Ⅱ receptor blocker. Am J Hypertens,2014 27:571-578.
  • 6Kahan T, Schwieler JH, Wall6n H, et al. Exercise induced platelet activation in essential hypertension: have we solved the puzzle? Reply. J Hypertens,2013,31:1917.
  • 7李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:386
  • 8Chobanian AV, Bakris GL, Black HR, etal. The seventh report o f the joint nationalcommittee on prevention, detection, evaluation,and treatment ofhigh blood pressure:the JNC7 report[J].JAMA,2003,289(19):2560-2572.
  • 9郜攀,宋双双.司良毅,等.2型糖尿病患者血浆Meprin-a水平与冠心病发病的相关性研究[J].中华临床医师杂志,2014,8(15):2775-2778.
  • 10Hochman DM, Feinstein RE, Stauter EC, et al. An office- based approach to emotional and behavioral risk factor reduc- tion for cardiovascular disease [J]. Cardiol Rev, 2013, 21 (5) :213-221.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部